نتایج جستجو برای: double dose vaccination

تعداد نتایج: 591550  

2012
Thomas G. Johannesson Ole S. Søgaard Martin Tolstrup Mikkel S. Petersen Jens M. Bernth-Jensen Lars Østergaard Christian Erikstrup

Untreated HIV infection results in severe perturbations of the B-cell population and hyporesponsiveness to vaccination. We studied associations between circulating B-cell subsets and antibody response to pneumococcal conjugate vaccine in treated and untreated HIV patients.Ninety-five HIV-infected adults were grouped according to antiretroviral therapy (ART) and CD4+ cell count as follows: 20 AR...

Journal: :Pediatrics 2016
Dana Perella Chengbin Wang Rachel Civen Kendra Viner Karen Kuguru Irini Daskalaki D Scott Schmid Adriana S Lopez Hung Fu Tseng E Claire Newbern Laurene Mascola Stephanie R Bialek

OBJECTIVES We examined overall and incremental effectiveness of 2-dose varicella vaccination in preventing community transmission of varicella among children aged 4 to 18 years in 2 active surveillance sites. One-dose varicella vaccine effectiveness (VE) was examined in those aged 1 to 18 years. METHODS From May 2009 through June 2011, varicella cases identified during active surveillance in ...

Journal: :Dermato 2022

There is increasing evidence of adverse events associated with the use COVID-19 vaccines. Here, we report a case SARS-CoV-2-vaccination-related onset pityriasis rubra pilaris (PRP) and provide an analysis previously reported cases in medical literature. A 67-year-old male presented 1-year history histopathologically proven PRP that first developed 14 days after receiving booster vaccination. Sk...

2011
Seung Cheol Kim Yong Sang Song Young-Tae Kim Young Tak Kim Ki-Sung Ryu Bhavyashree Gunapalaiah Dan Bi Hans L Bock Jong-Sup Park

OBJECTIVE The study assessed the immunogenicity and safety of human papillomavirus (HPV)-16/18 AS04-adjuvanted cervical cancer vaccine in healthy Korean women aged 15-25 years. METHODS Phase IIIB, double-blind, randomised (2:1), multi-centre trial was conducted in Korea from June 2007 to March 2008. The study enrolled 225 women in the HPV (N=149) and placebo (N=76) groups who received three d...

2016
Carlos A. DiazGranados Andrew J. Dunning Corwin A. Robertson H. Keipp Talbot Victoria Landolfi David P. Greenberg

BACKGROUND High-dose inactivated influenza vaccine (IIV-HD) is an alternative to the standard-dose inactivated influenza vaccine (IIV-SD) in the United States for influenza prevention in older adults. IIV-HD improved efficacy relative to IIV-SD in a randomized controlled trial. Recent observational studies suggest that previous influenza vaccination may influence the immunogenicity and effectiv...

Journal: :Vaccine 2017
Maria Norrby Timo Vesikari Lars Lindqvist Markus Maeurer Raija Ahmed Shahnaz Mahdavifar Sean Bennett J Bruce McClain Barbara M Shepherd Daner Li David A Hokey Ingrid Kromann Søren T Hoff Peter Andersen Adriëtte W de Visser Simone A Joosten Tom H M Ottenhoff Jan Andersson Susanna Brighenti

BACKGROUND Novel vaccine strategies are required to provide protective immunity in tuberculosis (TB) and prevent development of active disease. We investigated the safety and immunogenicity of a novel TB vaccine candidate, H4:IC31 (AERAS-404) that is composed of a fusion protein of M. tuberculosis antigens Ag85B and TB10.4 combined with an IC31® adjuvant. METHODS BCG-vaccinated healthy subjec...

2014
Laura L. Hammitt John Ojal Mahfudh Bashraheil Susan C. Morpeth Angela Karani Ahsan Habib Dorota Borys David Goldblatt J. Anthony G Scott

BACKGROUND The impact on carriage and optimal schedule for primary vaccination of older children with 10-valent pneumococcal non-typeable Haemophilus influenzae protein-D conjugate vaccine (PHiD-CV) are unknown. METHODS 600 Kenyan children aged 12-59 months were vaccinated at days 0, 60 and 180 in a double-blind randomized controlled trial according to the following vaccine sequence: Group A:...

Journal: :Vaccine 2014
Geert Leroux-Roels Cathy Maes Fien De Boever Magali Traskine Jens U Rüggeberg Dorota Borys

BACKGROUND New vaccines containing highly conserved Streptococcus pneumoniae proteins such as pneumolysin toxoid (dPly) and histidine-triad protein D (PhtD) are being developed to provide broader protection against pneumococcal disease. This study evaluated the safety, reactogenicity and immunogenicity of different pneumococcal protein-containing formulations in adults. METHODS In a phase I d...

Journal: :The Journal of infectious diseases 2008
Laura L Hammitt Lisa Bulkow Thomas W Hennessy Carolyn Zanis Mary Snowball James L Williams Beth P Bell Brian J McMahon

BACKGROUND Hepatitis A vaccination is effective in preventing disease. However, the duration of protection after vaccination is unknown. METHODS We enrolled persons who responded to a 3-dose primary series of hepatitis A vaccine. For adults, the first dose was 720 ELISA units (EU) of hepatitis A vaccine, readministered at 1 and 12 months after the first vaccination (hereafter, "0-1-12 months"...

Journal: :Cochrane Database of Systematic Reviews 2016

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید